Acumen Pharmaceuticals In... (ABOS)
NASDAQ: ABOS
· Real-Time Price · USD
1.16
-0.05 (-4.13%)
At close: Jun 27, 2025, 3:59 PM
1.12
-3.03%
After-hours: Jun 27, 2025, 05:50 PM EDT
-4.13% (1D)
| Bid | 1.1 |
| Market Cap | 69.96M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -116.25M |
| EPS (ttm) | -1.94 |
| PE Ratio (ttm) | -0.6 |
| Forward PE | -0.74 |
| Analyst | Buy |
| Ask | 1.15 |
| Volume | 493,376 |
| Avg. Volume (20D) | 254,633 |
| Open | 1.21 |
| Previous Close | 1.21 |
| Day's Range | 1.14 - 1.22 |
| 52-Week Range | 0.85 - 3.60 |
| Beta | 0.05 |
About ABOS
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ABOS
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ABOS stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts10 months ago
-9.03%
Acumen Pharmaceuticals shares are trading lower. T...
Unlock content with
Pro Subscription
1 month ago · seekingalpha.com
Acumen Pharmaceuticals, Inc. (ABOS) Q1 2025 Earnings Call TranscriptAcumen Pharmaceuticals, Inc. (NASDAQ:ABOS ) Q1 2025 Earnings Conference Call May 13, 2025 8:00 AM ET Company Participants Alex Braun - Head, Investor Relations Dan O'Connell - Chief Executive Officer ...
3 months ago · seekingalpha.com
Acumen Pharmaceuticals, Inc. (ABOS) Q4 2024 Earnings Call TranscriptAcumen Pharmaceuticals, Inc. (NASDAQ:ABOS ) Q4 2024 Earnings Conference Call March 27, 2025 8:00 AM ET Company Participants Alex Braun - Head, Investor Relations Dan O'Connell - Chief Executive Office...